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Background/aims: Attention-deficit/hyperactivity disorder (ADHD) is often overlooked 
in adults; moreover, the problem seems to be even more critical in women. In the pres-
ent, observational screening study, a clinical, particularly adult outpatient population was 
examined regarding frequency and severity of a likely ADHD, whereby sex differences 
were of particular interest.
Methods: 224 participants, 146 men and 78 women, were included. Based on data 
recorded with the self-rating WHO screening instrument Adult ADHD Self-Report Scale 
(ASRS-v1.1), it was examined how many participants were conspicuous for adult 
ADHD by exceeding a predefined cutoff value (COV) (COV ≥ 4 for ASRS-6, and ≥12 for 
ASRS-18). To examine frequency distributions, χ2 tests were conducted. For the inferen-
tial statistical comparison of means, t-tests for independent samples or Mann–Whitney 
U tests were calculated.
results: 34.4% of the sample was screened positive in the ASRS-v1.1 screener short 
version, ASRS-6, while 17.4% were conspicuous in the symptom checklist, ASRS-18. 
There were indeed more men screened positive, but the difference in the frequency 
between the sexes was not statistically significant, indicating a balanced sex ratio. 
Further, severity of ADHD core symptoms inattention and hyperactivity/impulsivity was 
examined by comparing ASRS-18 symptom subscale scores. In concordance with the 
hypothesis, men and women did not differ in severity of symptoms.
conclusion: Results indicate that women might be affected by ADHD in a comparable 
manner as men; this emphasizes the importance for the awareness of ADHD in both 
sexes in clinical practice.
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inTrODUcTiOn
Attention-deficit/hyperactivity disorder (ADHD) is a neurode-
velopmental disorder of multifactorial genesis that persists in 
50–75% of cases into adulthood (1–4). Estimations of worldwide 
prevalence in adults range between 1.2 and 7.3% (5–7).
Attention-deficit/hyperactivity disorder manifests in the core 
symptoms inattention (IA), hyperactivity (HYP), and impulsiv-
ity (I); moreover, emotional dysregulation and disorganization 
are further prominent symptoms in adults (8). ADHD is clas-
sified according to the International Statistical Classification of 
Diseases [ICD-10 (9)] especially used in clinical practice, and 
the current, Fifth Edition of Diagnostic and Statistical Manual 
of Mental Disorders [DSM-V (10)], which is mainly applied in 
research.
Even though ADHD is a common disorder in adulthood, 
it is often overlooked (11, 12). An undetected ADHD can lead 
to severe psychiatric, functional and also forensic impairment 
(13). Moreover, patients concerned are often undergoing treat-
ment due to other psychiatric disorders (11). Paying attention 
to comorbid disorders is important because they can mask 
symptoms of ADHD (14). Fayyad et  al. (5) reported a seven 
times higher risk of having three or more disorders such as mood 
disorders, anxiety disorders, and substance use disorders when 
being affected by ADHD (OR =  7.2). ADHD patients are at a 
higher risk for delinquency (15); moreover, there is a problem 
of a higher distractibility in traffic which may lead to a higher 
involvement in accidents (16, 17). This raises the question how 
the disorder can be recognized adequately, since the process of 
recognizing and diagnosing is apparently hampered considerably 
by the comorbidity of other psychiatric disorders.
Screening is a method to identify disorders either before 
they manifest, when there are subclinical symptoms or when 
the disorder is already manifest but not yet detected. It is a 
pre-diagnostic method to estimate the occurrence and sever-
ity of symptoms (18); however, it is not a substitute to clinical 
diagnosis. The screening for a disorder is generally the first step 
of the diagnostic process. It initiates timely and appropriate 
diagnostic and treatment interventions preventing further suf-
fering and impairments in major life activities for patients and 
reducing treatment costs. Screening is mostly conducted by the 
use of specific instruments, for example in the form of a self-
rating questionnaire (18). A screening test shall separate healthy 
persons from affected ones. If a screening test reveals a positive 
result by achieving a predefined cutoff value (COV), a detailed 
evaluation of the psychiatric and somatic medical history of the 
patient, including physical, intellectual, and biographical devel-
opment, clinical observation and differential diagnostics should 
follow (14). Specific diagnostic guidelines for ADHD in adults 
[see, e.g., Ref. (19)], a wide range of standardized and validated 
questionnaires and neuropsychological tests to objectify deficits 
of attention, working memory, and executive functions can 
facilitate and support the complex diagnostic process and the 
planning of further possible treatment (14).
Beyond the problem that ADHD in adults is often overlooked, 
recognizing the disorder adequately seems to be even more 
complex with specific regard to sex-related differences. Whereas 
there is a tremendous amount of research being conducted 
concerning ADHD in adults in general; however, findings regard-
ing sex differences are inconsistent and new findings seem to be 
lacking. Most of research focuses on men, whereas women are 
often underrepresented or non-existent within study samples, 
particularly in clinical samples [e.g., Ref. (1, 20, 21)].
Regarding the prevalence of ADHD among men and women, 
ratios of approximately 3:1 were reported in population-based 
samples (21, 22). In a community-based sample with over 9,000 
participants who were between 7 and 29 years old, Ramtekkar 
et  al. (23) found male-to-female ratios of 2.09:1 for children, 
2.56:1 for adolescents, and 2.15:1 for adults, respectively. Krause 
et  al. (24) assumed an average male-to-female ratio of adult 
ADHD of 2–3:1 based on a clinical sample. Likewise, Fayyad 
et  al. (5) and Kessler et  al. (6) assumed that the prevalence of 
ADHD is higher in men than in women, specifying a male-to-
female ratio of 1.6:1 (6).
Nevertheless, there are a few studies that also examined 
ADHD specifically in women [e.g., Ref. (20, 24, 25)]. Quinn (25), 
who called ADHD in women a hidden disorder, claimed that 
ADHD is often overlooked or misdiagnosed in women because 
their symptoms (e.g., forgetfulness, disorganization) are “less 
overt” (p. 579) than in men who show more often disruptive 
behaviors. For example, HYP in women shows up more often in a 
hyper talkative behavior instead of being physically active. Lauth 
and Raven (26) also assumed that the disorder is often overlooked 
in girls because they are less hyperactive and that symptoms in 
girls are not that obvious, e.g., at school (27). Differences in the 
manifestation and type of comorbid disorders make it even more 
complicated to recognize the disorder adequately in women (25).
Grevet et al. (28) and Rasmussen and Levander (29) found 
that men and women did not differ in symptom manifestation 
and severity. Biederman et al. (30) likewise did not find sex dif-
ferences in the frequency of subtypes, whereby the combined 
subtype was the most frequent among both sexes, followed by the 
inattentive and the hyperactive-impulsive subtype. Ramtekkar 
et al. (23) determined that the inattentive subtype was the most 
frequent and the hyperactive–impulsive the least frequent sub-
type in both sexes. These findings are consistent with Krause 
et  al. (24) who likewise did not find sex differences among 
ADHD subtypes in adults. Retz-Junginger et  al. (31) found, 
when using self-report instruments, sex differences in I but not 
in IA and HYP. In the same study, they found sex differences 
in IA but not in HYP and I when applying semi-standardized 
interviews (31). Although there were certain sex differences 
between the examined ADHD patients, Retz-Junginger et  al. 
(31) concluded that the found differences in core symptoms 
were not particularly prominent. However, it is important to 
take into account that methodological issues, such as selection 
of instruments (31), rater biases, comorbid disorders, referral 
source (21), and small sample sizes (27), may influence results 
of given findings.
The present, observational study was designed to record 
ADHD symptoms in adults in a clinical population. To our 
knowledge, there has not been done any research concerning the 
examination of sex differences in ADHD on the level of screening 
tests. Therefore, the following research questions are examined.
TaBle 1 | Characteristics of participants (N = 224) and clinics of registration.
M (SD) or absolute number (%)
sex
Male: female 146 (65.2%): 78 (34.8%)***
age (years)
Male: female 36.66 (11.01): 34.91 (12.22)+
Overall 36.05 (11.45)
Range 18.00–75.00
clinic of registration
ADS 84 (37.5%)
VTA 46 (20.5%)
ZA 38 (17.0%)
ZDK 20 (8.9%)
ZASS 13 (5.8%)
ZFM 10 (4.5%)
U3 8 (3.6%)
FAM 5 (2.2%)
Total 224 (100.0%)
p, p-values for sex obtained by χ2 test (***p < 0.001) and age by unpaired t-test; 
clinic of registration, clinic where the participants completed the questionnaires; ADS, 
Ambulance Addiction Services (Ambulanz für Sucht); VTA, Ambulance Behavioral 
Therapy (Verhaltenstherapie Ambulanz); ZA, Central Patient Admission (Zentrale 
Aufnahme); ZDK, Centre for Diagnostic and Crisis Intervention (Zentrum für Diagnostik 
und Krisenintervention); ZASS, Center for Affective, Stress and Sleep Disorder 
(Zentrum für Affektive-, Stress- und Schlafstörungen); ZFM, Centre for Psychotic 
Disorders and Transcultural Psychiatry (Zentrum für psychotische Erkrankungen 
und transkulturelle Psychiatrie); U3, Inpatient Unit for Substance Dependence and 
Addiction (Stationäre Abteilung für Abhängigkeit und Sucht); FAM, Forensic Ambulance 
(Forensische Ambulanz).
***p < 0.001.
+p = 0.276.
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First, it was analyzed how many participants within the 
population report conspicuous ADHD symptoms on a validated 
screening questionnaire, being consequently likely to have an 
adult ADHD. The frequency of conspicuous participants was 
compared to the frequency of inconspicuous participants. 
Second, with regard to sex, it was examined how many men and 
women were conspicuous for ADHD. Third, men and women 
were analyzed regarding the severity of the core symptoms 
IA and HYP/I by comparing conspicuous symptom scores of 
the screening questionnaire. Considering the current state of 
research, it was hypothesized that there are significant more 
men than women with conspicuous ADHD symptoms. Given 
the heterogeneous findings of existing literature, it was rarely 
possible to make an assumption about sex differences regarding 
symptom severity across ADHD core symptoms in the examined 
population. However, because the majority of the recent findings 
about sex differences in adults did not find significant differences, 
it was predicted that men and women do not differ in symptom 
severity assessed by the screening questionnaire.
MaTerials anD MeThODs
Participants
The sample included a total of 224 patients who were 
recruited across eight, mainly outpatient clinics that belong 
to the University of Basel Psychiatric Clinics (UPC) in Basel, 
Switzerland. Patients in these eight clinics usually do not 
undergo an ADHD screening. Only for this specific study these 
clinics screened patients. Exclusion criteria were first of all an 
insufficient command of German, an intelligence quotient of 
IQ < 85, schizophrenia or other psychotic disorders, a current 
or most recent episode of a manic or current severe major 
depressive disorder, acute stress disorder, or substance intoxica-
tion and withdrawal. Participants’ characteristics are presented 
in Table 1. There were 146 (65.2%) men and 78 (34.8%) women, 
which is approximately equivalent to a male-to-female ratio 
of 2:1 with a statistical difference [χ2(1, N  =  224)  =  20.64, 
p < 0.001]. Two participants were excluded due to the amount 
of missing answers (>20%). The age of the participants ranged 
from 18 to 75 years (M = 36.05, SD = 11.45), whereby men and 
women did not differ in average age [t(222) = 1.09, p = 0.276]. All 
participant were attended in one of the eight clinics at UPC with 
group differences in gender [χ2(7, N = 243) = 18.07, p = 0.012] 
and age [ANOVA: F(7, 224) =  8.44, p <  0.001]. Participants 
gave written informed consent. The Ethics Committee of Basel 
(Ethikkommission beider Basel) approved the study (reference 
number: 384/08).
Procedure
The study was conducted between March 2013 and August 
2014. In order to collect the data about adult ADHD, ASRS-v1.1 
(32, 33) was distributed to eight, particularly outpatient clinics 
at UPC (see Table 1). The employees of the respective clinic, first 
of all psychiatrists and psychologists, passed the questionnaire 
to the participants and obtained written informed consent. The 
instruction how it needed to be completed was provided on the 
questionnaire itself. The questionnaires were regularly collected, 
evaluated, and sent back to the attending psychiatrists and 
psychologists, accompanied by a recommendation of diagnostics 
and/or treatment. Patients who exceeded the COV were recom-
mended for a specific ADHD consultation which is offered by 
the ADHD Special Consultation of the Outpatient Department 
at UPC.
instruments
Adult ADHD Self-Report Scale [ASRS-v1.1 (32, 33)]: The self-
rating scale is based on the 18 DSM-IV ADHD criteria and may 
provide information suggesting the need of a more in-depth 
diagnostic evaluation. Six (part A) of the 18 questions were found 
to be the most predictive of symptoms consistent with ADHD in 
adulthood (33). The 12 remaining questions form part B of the 
checklist providing additional cues on the patient’s symptoms. 
The instrument, with its five-point scale from never (0) to very 
often (4), takes about 5 min to complete. The total score is cal-
culated by summing the values of all items. The higher the score 
is the more symptoms are pronounced. In addition to the sum 
score of the checklist, the two subscales IA and HYP/I can be 
calculated. While part A helps to identify patients correctly, part 
B records the severity of symptoms. Part A is seen as the short 
version of the checklist [ASRS-6 (33)]. This consists of four items 
from the IA and two items of the HYP/I subscale. By reaching 
a COV of 4 in ASRS-6, an adult ADHD is likely. This COV is 
reached, when an individual exceed a certain value in order for 
the symptom to be counted (all symptom-ratings exceeding 1 or 
2 on the five-point scale). Kessler et al. (33) were able to establish 
TaBle 3 | Descriptive statistics of ASRS-v1.1 subscales IA and HYP/I by COV 
and sex.
subscale sex n M SD p-Value
Overall
IA Male 146 16.88 7.48 0.305
Female 78 15.85 6.64
HYP/I Male 146 15.86 6.91 0.140
Female 78 14.45 6.52
asrs-6 COV (≥4)
Exceeded IA Male 55 23.24 4.99 0.775
Female 22 22.86 5.53
HYP/I Male 55 20.65 5.69 0.109
Female 22 18.32 5.74
Not exceeded IA Male 91 13.04 5.97
Female 56 13.09 4.75
HYP/I Male 91 12.96 5.91
Female 56 12.93 6.21
asrs-18 COV (≥12)
Exceeded IA Male 29 25.97 4.73 0.984
Female 10 26.00 4.90
HYP/I Male 29 24.14 4.30 0.301
Female 10 22.40 5.15
Not exceeded IA Male 117 14.63 6.23
Female 68 14.35 5.46
HYP/I Male 117 13.80 5.82
Female 68 13.28 5.87
IA, inattention; HYP/I, hyperactivity/impulsivity; ASRS-6, Adult Attention-Deficit/
Hyperactivity Disorder (ADHD) Self-Report Scale, ASRS-v1.1 screener; ASRS-18, Adult 
ADHD Self-Report Scale, ASRS-v1.1 symptom checklist; COV, cutoff value.
TaBle 2 | ASRS-v1.1 COVs of the overall sample (N = 224) and separated by 
sex.
Overall sex
Male Female
n (%) n (%) n (%) χ2 (df) p-Value
asrs-6 COV (≥4) 2.02 (1) 0.155
Exceeded 77 (34.4) 55 (37.7) 22 (28.2)
Not exceeded 147 (65.6) 91 (62.3) 56 (71.8) 21.86 (1) <0.001*
asrs-18 COV (≥12) 1.75 (1) 0.185
Exceeded 39 (17.4) 29 (19.9) 10 (12.8)
Not exceeded 185 (82.6) 117 (80.1) 68 (87.2) 95.16 (1) <0.001*
*The percentage of participants who exceeded COVs differed from the percentage of 
those who did not exceed COVs (*p < 0.05).
χ2, chi-square; df, degrees of freedom; p, p-values. ASRS-6, Adult Attention-Deficit/
Hyperactivity Disorder (ADHD) Self-Report Scale, ASRS-v1.1 screener; ASRS-18, Adult 
ADHD Self-Report Scale, ASRS-v1.1 symptom checklist; COV, cutoff value.
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good psychometric properties for the screener (ASRS-6) and the 
full version (ASRS-18): sensitivity: 68.7 versus 56.3%, specific-
ity: 99.5 versus 98.3%, total classification accuracy: 97.9 versus 
96.2%, and Cohen’s κ: 0.76 versus 0.58. Buchli-Kammermann 
et al. (11) determined the psychometric quality of the German 
version. The authors determined similar values for both ver-
sions (ASRS-6 versus ASRS-18): sensitivity: 66.6 versus 72.3%; 
specificity: 64.9 versus 68.1%, Cronbach’s α: 0.73 versus 0.89. 
For the screening process, the ASRS-6 proved to be particularly 
relevant. Ramos-Quiroga et al. (34) revealed a new strategy in 
scoring symptoms by using a quantitative ranking between 0 
and 24 points for either subscale (IA and HYP/I) with a COV 
at 12 points (sensitivity: 96.7%, specificity: 91.1%, Cohen’s κ: 
0.88). Yeh et al. (35) who also recently examined the ASRS-v1.1 
likewise used a quantitative ranking by classifying patients with 
a sum score of 24 on either subscale having highly likely ADHD, 
patients with scores of 17–23 of likely and those with scores of 
0–16 of unlikely having ADHD. For the current study the short 
version (ASRS-6) as well as the full version (ASRS-18) of this 
screening instrument was used. The COV of 12 points in the full 
version (ASRS-18) proposed by Ramos-Quiroga et al. (34) was 
adopted.
Data analysis
For the data analyses, IBM SPSS Statistics version 21 was used. 
First, the sample was described regarding probable differences in 
gender, age, and clinics. To examine frequency distributions, χ2 
tests were conducted. For the inferential statistical comparison of 
means, t-tests for independent samples were calculated. In cases 
where distribution requirements were violated, Mann–Whitney 
U tests were conducted.
resUlTs
Frequency of Positive aDhD screenings  
in the Overall sample
Overall, there were significantly more participants who did not 
exceed the COVs in ASRS-6 and ASRS-18 than participants who 
exceeded the COVs. 34.4% of the participants screened above 
and 65.6% below the COV of ASRS-6. In ASRS-18, 17.4% of 
the participants screened above and 82.6% below the COV. The 
percentage of participants who exceeded the COV in ASRS-6 
differed from the percentage of those who exceeded the COV in 
ASRS-18 [χ22(1, N = 224) = 64.17, p < 0.001]. These results are 
presented in Table 2.
Frequency of Positive aDhD screenings  
in Men and Women
Of the 146 men, 55 exceeded the COV in ASRS-6 and 29 in 
ASRS-18. Of the 78 women, 22 exceeded the COV in ASRS-6 
and 10 in ASRS-18. This means that 37.7% of all men within the 
sample exceeded the COV in ASRS-6 and 19.9% in ASRS-18. 
28.2% of all women exceeded the COV in ASRS-6 and 12.8% 
in ASRS-18. Hence, there were more men with a likely ADHD 
in the study population; however, the belonging to either sex 
group did not have a significant impact of exceeding the COV, 
neither in ASRS-6 [χ22(1, N =  224) =  2.02, p =  0.155] nor in 
ASRS-18 [χ22(1, N = 224) = 1.75, p = 0.185]. These results are 
also presented in Table 2.
sex-specific symptom severity
Ms and SDs of the participants’ achieved symptom scores that 
were of relevance for the interpretation of the following statisti-
cal tests, are presented in Table 3. To examine whether men and 
women of the overall sample differ regarding symptom severity, 
two-tailed t-tests for independent samples were conducted. 
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Among the 224 participants, men had slightly higher symptom 
scores on both subscales; however, the differences were not 
significant, neither on subscale IA [t(222) = 1.03, p = 0.305] nor 
on subscale HYP/I [t(222) = 1.48, p = 0.140].
Among the participants who were conspicuous for ADHD 
in ASRS-6, men also had higher symptom scores, but again, the 
differences between men and women on subscale IA [t(75) = 0.29, 
p =  0.775] and subscale HYP/I [t(75) =  1.62, p =  0.109] were 
not significant. Among the participants who were conspicuous 
for ADHD in ASRS-18, women had slightly higher scores on 
subscale IA, while men had higher scores on subscale HYP/I. 
However, there were likewise no significant differences between 
men and women each on subscale IA [t(37) = 0.02, p = 0.984] and 
subscale HYP/I [t(37) = 1.05, p = 0.301].
Because the assumption of normality distribution was 
violated among the sexes, Mann–Whitney U tests were conducted. 
Among the 224 participants, average symptom scores on subscale 
IA [U(78,146) = 5,093, p = 0.193] and HYP/I [U(78,146) = 5,050.5, 
p = 0.163] did not differ between the sexes. There were likewise 
no significant differences between men and women among those 
participants above the COV in ASRS-6 for IA [U(22,55) = 597, 
p =  0.928] and HYP/I [U(22,55) =  457, p =  0.094] and those 
above the COV in ASRS-18 for IA [U(10,29) = 139, p = 0.846] 
and HYP/I [U(10,29) = 132, p = 0.674]. As predicted, men and 
women did not differ in the core symptomatology calculated for 
both symptom subscales, IA and HYP/I.
DiscUssiOn
The present study was designed, first, to examine how many 
participants are likely to have an adult ADHD by achieving a 
conspicuous COV in the screening questionnaire ASRS-v1.1. 
Second, it was of interest how many men and women are likely 
to have an ADHD, hypothesizing that there are significantly 
more men with a likely ADHD than women. And third, men 
and women were examined regarding differences in the severity 
of ADHD core symptoms IA and HYP/I assessed by ASRS-18, 
predicting that there are no significant differences in severity 
between the sexes.
It is noteworthy that with 34.4% of participants who likely have 
an ADHD according to ASRS-6 and 17.4% according to ASRS-18, 
respectively, the rates obviously differ (see Table 2). Within this 
framework, there is no final explanation for this difference. The 
quality of psychometric criteria of both ASRS-v1.1 versions were 
recently examined by Konstenius et al. (36) on a female offenders 
sample, and they also found different prevalence rates in ASRS-6 
and ASRS-18. However, they found that both versions had a con-
vincing sensitivity of 100%, but that ASRS-18 had a lower speci-
ficity (45 versus 66%) and a lower positive predictive value (42 
versus 55%) than ASRS-6. Either way, symptom subscales scores 
from ASRS-18 were finally useful for the present study because 
they revealed more detailed information about symptom severity, 
assessing for example symptoms of I that were not considered 
in ASRS-6. The findings of the present study support previous 
findings which indicated that ADHD is a frequent disorder in 
adults (5, 6, 37), emphasizing the importance of screening and 
the initiation of further diagnostics in case of a positive screening 
result.
In contrast to our prediction about the frequency of a sus-
pected ADHD in men and women, there were namely more men 
than women who exceeded the COV of ASRS-6 and/or ASRS-18; 
however, the difference in frequency between the sexes was not 
statistically significant. Nevertheless, this finding is meaningful, 
as it shows that the percentage of men screened positive for 
ADHD is indeed higher than in women, but the difference is not 
that large as supposed by a majority of other studies, particularly 
studies with children samples [e.g., Ref. (21, 38)], indicating that 
adult women are affected almost as often as men. This finding is 
supported by the assumption that sex ratios are more balanced in 
adults than in children (24).
In concordance with our prediction, men and women did not 
differ in the severity of the core symptoms IA and HYP/I. This 
finding is supported by other empiric studies which assumed that 
there are no or only few differences between men and women 
concerning the core symptomatology [e.g., Ref. (28, 29, 31, 39)]. 
Retz-Junginger et al. (31) examined sex differences with different 
types of instruments and revealed inconsistent results. For self-
reports, they indeed found only some sex differences in I, con-
cluding that male and female ADHD patients seem to be “more 
similar than different and that symptoms of ADHD might not be 
sex-specific” [(31), pp. 100]. However, the study of Robison et al. 
(40) presented to some extent other. In this study comparing the 
attributes of men and women in a large, controlled ADHD study, 
there were significant differences regarding the type of ADHD. 
Women were more often given a combined ADHD diagnosis 
that men and men had a higher frequency of inattentive subtype 
compared to women.
This study bears theoretical and practical implications. This 
is, apparently, one of the first studies that examined sex differ-
ences on the base of an ADHD self-report screening question-
naire. It was previously shown that exceeded COVs on both 
ASRS-v1.1 versions, ASRS-6 and ASRS-18, are good predictors 
for adult ADHD (11, 33–35). Therefore, it might be important 
and helpful to screen patients who are undergoing psychiatric 
treatment due to other disorders preventively and routinely for 
ADHD.
This study contributes to the sensitization to ADHD in adults, 
particularly to screening ADHD in women. With 28.2% women 
screened positive in ASRS-6 and 12.8% in ASRS-18, it seems to 
be obvious that ADHD in women is not a hidden disorder as 
Quinn (25) claimed. In the contrary, although the number of 
positively screened men exceeds the one of positively screened 
women, the results indicate that men with ADHD seem not to 
be a significant majority. Furthermore, both sexes seem to be 
comparably impaired by ADHD, as shown, for example, in Retz-
Junginger et al. (39). Robison et al. (40) could even observe that 
women with ADHD are more impaired than men and show a 
more complicated presentation of the disorder with greater rates 
of affective or emotional symptoms. They had higher level of 
ADHD symptomatology, had more symptoms of depression and 
anxiety and were more likely to have problems with sleep and 
somatic complaints.
6Corbisiero et al. Screening ADHD Sex Differences
Frontiers in Psychiatry | www.frontiersin.org June 2017 | Volume 8 | Article 115
It is important to acknowledge some limitations. Since this is a 
screening study without further diagnostic assessment, the results 
should be interpreted against the background of a tendency 
which can be put in relation to other studies. However, the find-
ings about frequency and severity are not to be directly applied to 
the findings of studies which were made with diagnosed ADHD 
patients. Moreover, due to the fact that the study design is clinical 
and observational, there is no healthy control group. This might 
restrict the generalization to non-clinical populations. Besides, 
participants were not randomized to the different clinics. Having 
an equal amount of participants in each clinic would eliminate the 
impact of this variable and strengthen the explanatory power of 
the variables of interest.
There are also several risks of bias. The present data base on 
self-reports. It was found that adults tend to underestimate their 
ADHD symptoms (6, 41). Therefore, answers could be biased to 
some extent. Moreover, a more balanced sex ratio in the overall 
sample was desirable, but, given existing literature, the present 
male-to-female ratio of approximately 2:1 is often seen in clinical 
populations [e.g., in Ref. (31)] and can be, therefore, considered 
as representative within this type of population. In order to make 
statements about general population in future, a more balanced 
sex proportion will be necessary.
It will be important to replicate this study by extending the 
method of assessing ADHD symptoms in a randomized, con-
trolled trial with more participants. Namely, there are symptoms 
beyond the core symptomatology that are estimated to be particu-
larly frequent in females such as emotional dysregulation (40). 
Examples of ADHD self-report instruments that were shown to 
have robust psychometric criteria and validity recently (42, 43) 
and that assess ADHD typical symptoms beyond ASRS-v1.1, 
such as emotional dysregulation, are the Conners’ Adult ADHS 
Rating Scales (44) and Wender-Reimherr Adult Attention Deficit 
Disorder Rating Scale (42, 45). Retz-Junginger et  al. (39) and 
Robison et al. (40) found sex differences in emotional dysregu-
lation with women having higher scores when applied UTAH 
criteria (45, 46). However, further results of these two studies 
are contradictory. While Retz-Junginger et al. (39) did not find 
sex differences in severity of the core symptomatology of ADHD 
according to DSM-IV-TR, Robison et  al. (40) could show that 
women have more symptoms of IA and disorganization than men.
Further, the assessment and analysis of other psychiatric and 
comorbid disorders of the participants is highly recommendable 
in order to make more accurate statements regarding ADHD, 
gender differences, and its comorbid psychiatric disorders bear-
ing in mind the previous mentioned risk of overlooking ADHD 
in adults (11). Recent findings by Park et al. (47) who assessed 
ADHD symptoms by ASRS-6 and examined further comorbid 
disorders in an epidemiological Korean study showed that 
ADHD was highly correlated with somatoform disorders, sleep 
disorders, mood disorders, suicidality, anxiety disorders, and 
substance abuse. Given the elevated risk of comorbid disorders 
(5, 14), it is possible that women and men differ in type and 
frequency of comorbid disorders (29). There are findings that 
assume for example mood disorders, anxiety disorders, and 
personality disorders to be more frequent in women with ADHD 
than in men with ADHD (48). The clinics of registration may 
have a significant impact on the analysis of interest. Since there is 
a broad range of psychiatric disorders treated in the participating 
clinics, this recalls the problem stated in the introduction that 
ADHD can be masked through other psychiatric and comorbid 
disorders and remains undetected without screening (14). Finally, 
another aspect should be considered in further studies: Other 
psychiatric disorders might mimic ADHD symptoms, leading 
to false-positive screening of ADHD. To further understand the 
gender distribution in ADHD in a clinical sample, it is mandatory 
to consider all these mentioned points.
cOnclUsiOn
Screening for ADHD is a useful and reliable method to detect 
adult ADHD in a clinical population, a disorder that is of 
important relevance in men and women and that should not be 
overlooked. ADHD in women is as common as in men; therefore, 
it deserves more attention in women. Screening for ADHD can 
guide subsequent diagnostic follow-up assessments with the 
establishment of appropriate treatment plans which can have a 
positive impact on the overall treatment success.
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